CRL
Charles River Laboratories International, Inc.
Stock
$290.19+3.36 (+1.17%)Close Oct 2, 2026
- Total assets, 2025
- $7.1B
- YoY, 2025
- −5.2%
- 5-year CAGR
- +5.4%
- 10-year CAGR
- +13.2%
Total assets
Total assets by fiscal year
| Period | Total assets | YoY |
|---|---|---|
| 2025 | $7.1B | −5.2% |
| 2024 | $7.5B | −8.1% |
| 2023 | $8.2B | +7.8% |
| 2022 | $7.6B | +8.2% |
| 2021 | $7.0B | +27.9% |
| 2020 | $5.5B | +17.0% |
| 2019 | $4.7B | +21.7% |
| 2018 | $3.9B | +31.6% |
| 2017 | $2.9B | +8.0% |
| 2016 | $2.7B | +31.1% |
| 2015 | $2.1B | +10.6% |
| 2014 | $1.9B | +14.6% |
| 2013 | $1.6B | +2.9% |
| 2012 | $1.6B | +1.8% |
| 2011 | $1.6B | −10.1% |
| 2010 | $1.7B | −21.4% |
| 2009 | $2.2B | — |